Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients.
about
Radionuclide methods and instrumentation for breast cancer detection and diagnosis.Vision 20/20: Mammographic breast density and its clinical applicationsComparison of breast specific gamma imaging and molecular breast tomosynthesis in breast cancer detection: Evaluation in phantoms.Implementation and evaluation of an expectation maximization reconstruction algorithm for gamma emission breast tomosynthesisNuclear imaging of the breast: translating achievements in instrumentation into clinical useMolecular breast imaging: an emerging modality for breast cancer screening.Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.Background parenchymal uptake during molecular breast imaging and associated clinical factors.(99m)Tc-MDP bone scintigraphy of the hand: comparing the use of novel cadmium zinc telluride (CZT) and routine NaI(Tl) detectorsCollimator design for a dedicated molecular breast imaging-guided biopsy system: proof-of-concept.Contrast-noise-ratio (CNR) analysis and optimisation of breast-specific gamma imaging (BSGI) acquisition protocols.Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control studyHalf-time Tc-99m sestamibi imaging with a direct conversion molecular breast imaging system.Adsorption of 99mTc-sestamibi onto plastic syringes: evaluation of factors affecting the degree of adsorption and their impact on clinical studies.99mTc-sestamibi using a direct conversion molecular breast imaging system to assess tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancerComparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer.Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis.Comparative Diagnostic Utility of Low-Dose Breast-Specific Gamma Imaging to Current Clinical Standard.Technical Note: Development of a combined molecular breast imaging/ultrasound system for diagnostic evaluation of MBI-detected lesions.Evaluation of a novel collimator for molecular breast tomosynthesis.Quantitation of tumor uptake with molecular breast imaging.The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy.
P2860
Q26823614-EBF7E7BF-E4C8-454C-AF83-8E3BB9E30EFEQ28081408-046C9BBB-3201-4DD8-B9E7-B351098AD1CAQ30279081-D4CA2529-F2B2-4886-B7D5-C73ABB79B9E5Q30416129-A17BA5D8-E761-4FB0-9CD8-C0B0713F5577Q30419180-922B11E3-4B62-46D3-8ED3-F25B4EE03199Q35002382-6A0A3168-5C27-4B06-8B04-230568B08B83Q35580579-18577FE3-5C38-4F88-BE1E-55F39B256D97Q35580614-0D2FFBD2-002D-47DF-9DBD-182BE81A18DAQ36277871-0C11B57B-AC5B-4D00-8934-0AF0F0C72158Q36510676-886EFB10-4F0F-43AC-843E-349F9EE01B27Q36828153-6D7D5281-9492-4C80-84F7-86491547B9E4Q36836825-46008D33-15FE-4EAB-8DCC-A06C7B64F421Q37510620-DED58B09-55A3-4584-AEC9-699C9AAFB625Q37531629-30728EE3-DF68-47B7-86E5-C6F7BF005AF6Q37584757-740CAA95-183A-4365-91CA-3F45C8F08867Q37586989-DF2D11E5-6F8C-4C2B-BD8F-06A763E89841Q38059808-F6ABA4A0-57B0-4F3C-8389-11ABE5CD7AADQ38667905-102ACF25-72A3-49DE-8FD3-D22C94373DDEQ38764553-8950558A-E4D4-4328-BE3D-CB2B7680380FQ42688302-867E89FC-4227-4C08-A24F-E2463C5D88AAQ48010304-7AF8A243-B861-44D9-8F72-3D3E081C9747Q50050762-6BDA4D9F-ED17-4E9A-B290-6D8CB38CDA8AQ55346981-50E8FD1C-40FF-48DC-A18C-2D06729B2B15
P2860
Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Proof of concept for low-dose ...... rt II. Evaluation in patients.
@ast
Proof of concept for low-dose ...... rt II. Evaluation in patients.
@en
type
label
Proof of concept for low-dose ...... rt II. Evaluation in patients.
@ast
Proof of concept for low-dose ...... rt II. Evaluation in patients.
@en
prefLabel
Proof of concept for low-dose ...... rt II. Evaluation in patients.
@ast
Proof of concept for low-dose ...... rt II. Evaluation in patients.
@en
P2093
P2860
P356
P1433
P1476
Proof of concept for low-dose ...... rt II. Evaluation in patients.
@en
P2093
Amanda L Weinmann
Amy L Conners
Carrie B Hruska
Christina M Tello Skjerseth
Cindy L Tortorelli
Deborah J Rhodes
Eric M Wagenaar
Michael K O'Connor
Robert W Maxwell
P2860
P304
P356
10.1118/1.4719959
P407
P577
2012-06-01T00:00:00Z